Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04214821` - The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%	Phase 1/Phase 2
Completed	`NCT00461656` - Povidone-iodine Antisepsis for Strabismus Surgery	Phase 4
Completed	`NCT00136344` - Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery	N/A
Completed	`NCT04568213` - Hypochlorous Acid Disinfection Prior to Cataract Surgery	Phase 3
Terminated	`NCT01496794` - Endophthalmitis Cultures	N/A
Completed	`NCT00406913` - Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery	N/A
Recruiting	`NCT05079854` - Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis	Phase 4
Recruiting	`NCT05432336` - Complex Ocular Infection, Optimization of Microbiological Diagnosis
Recruiting	`NCT02810587` - Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics	N/A
Completed	`NCT00398658` - Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis	Phase 4
Recruiting	`NCT04035369` - Endophthalmitis Post Intravitreal Injections	N/A
Not yet recruiting	`NCT03420820` - Concentrating on Antisepsis: 5% vs. 10% Povidone-Iodine Prior to Intravitreal Injection	N/A
Withdrawn	`NCT00335231` - Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract Surgery	N/A
Not yet recruiting	`NCT03244072` - Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery	Phase 2/Phase 3
Completed	`NCT01323868` - Endogenous Endophthalmitis in the Inpatient Setting	N/A
Completed	`NCT03363295` - Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis	Phase 4
Suspended	`NCT02590523` - Intracameral Antibiotic Safety Study	Phase 3
Terminated	`NCT02770729` - Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.	Phase 3
Not yet recruiting	`NCT02324166` - Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain	Phase 4
Completed	`NCT02595359` - Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis	Phase 2

NCT number	NCT06268561
Study type	Observational
Source	Centre Hospitalier Universitaire de Saint Etienne
Contact	Thibaud GARCIN, MD PhD
Phone	(0)477829662
Email	thibaud.garcin@chu-st-etienne.fr
Status	Recruiting
Phase
Start date	June 5, 2023
Completion date	June 2024

Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms